Research

Energy balance

Resveratrol reduces de novo lipogenesis (fat synthesis) and fatty acid uptake in adipose tissue by inhibiting enzymes like FAS, ACC, and LPL.

Resveratrol appears to reduce the body's ability to synthesize new fat (lipogenesis) and take up fatty acids from the blood (via LPL inhibition) in animal models. This contributes to reduced fat depots, particularly in obese subjects. The effect is seen on enzymes like FAS and ACC.

ModerateSupportsMEDIUM confidence
Both the inhibition of de novo lipogenesis and adipose tissue fatty acid uptake mediated by lipoprotein lipase play a role in explaining the reduction in body fat which resveratrol induces.
Leixuri Aguirre et al. · Molecules · 2014

Why this rating

Supported by multiple in vivo animal studies showing reduced fat depots and enzyme activity, but human clinical data is sparse.

Source

Resveratrol: Anti-Obesity Mechanisms of Action

Leixuri Aguirre et al. · Molecules · 2014

DOI 10.3390/molecules191118632

narrative_reviewCited 203×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →